Markets:

Overview

News

Currencies

International

Treasuries

Gilead Sciences (NQ:GILD)

124.08 -0.21 (-0.16%)

Streaming Delayed Price Updated: 11:14 AM EST, Dec 22, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Gilead Sciences

< Previous 1 2 3 4 5 6 7 8 9

...

69 70 Next >

Is Gilead Sciences Gaining or Losing Market Support? ↗

August 13, 2025

Via Benzinga

GILD Q2 Deep Dive: HIV Franchise Drives Growth, New Launches and Pipeline in Focus

August 12, 2025

Biopharmaceutical company Gilead Sciences (NASDAQ:GILD) beat Wall Street’s revenue expectations in Q2 CY2025, with sales up 1.8% year on year to $7.08 billion. On the other hand, the company’s...

Via StockStory

Kymera Revenue Drops 55 Percent in Q2 ↗

August 11, 2025

Via The Motley Fool

Topics Intellectual Property

Market Monitor News August 11 BMO - Nasdaq Breaks Records, But The Trade Desk Hits a Wall ↗

August 11, 2025

Markets ended the week in high spirits, but not everyone joined the party.

Via Chartmill

Gilead Stock Showered With Upgrades, Price Target Hikes After Upbeat Q2, Guidance Lift: Retail’s Turned Exuberant ↗

August 08, 2025

Via Stocktwits

Earnings Scheduled For August 7, 2025 ↗

August 07, 2025

Via Benzinga

Gilead Sciences's Earnings Outlook ↗

August 06, 2025

Via Benzinga

Gilead Sciences Shares Soar; Analysts Lift Targets On HIV Strength And Yeztugo Outlook ↗

August 09, 2025

Upbeat guidance boosts confidence despite competitive pressures.

Via Talk Markets

Wall Street's Resilient Rally: What's Driving the Positive Momentum

August 08, 2025

Wall Street has experienced a broadly positive day, marked by a resilient rally that has added over $1 trillion in market value. This surge in investor confidence is primarily driven by a confluence of...

Via MarketMinute

Topics Artificial Intelligence Economy Electric Vehicles

Earnings Season Boosts Confidence: Gilead and Expedia Lead Strong Corporate Results

August 08, 2025

The second quarter 2025 earnings season has largely concluded, delivering a powerful shot of optimism to the financial markets. Against a backdrop of persistent economic uncertainties and geopolitical...

Via MarketMinute

Topics Artificial Intelligence Economy Intellectual Property

Top S&P500 movers in Friday's session ↗

August 08, 2025

Uncover the latest developments among S&P500 stocks in today's session. Stay tuned to the S&P500 index's top gainers and losers on Friday.

Via Chartmill

Tech Stocks Eye Record Highs As Magnificent Seven Top $19.5 Trillion: What's Moving Markets Friday? ↗

August 08, 2025

Tech stocks staged a full rebound from last Friday's sell-off, with the Nasdaq 100 surging to 23,600 — just shy of the 23,700 all-time high set in late July, as the week’s strong sector earnings and...

Via Benzinga

Earnings Season Highlights: Gilead Sciences and Expedia Group Post Strong Results

August 08, 2025

The second quarter of 2025 has largely concluded as a period of unexpected strength for U.S. corporations, with a significant number of companies not only meeting but exceeding analyst expectations....

Via MarketMinute

Topics Artificial Intelligence Earnings Economy

Friday's session: top gainers and losers in the S&P500 index ↗

August 08, 2025

Stay updated with the movement of S&P500 stocks in today's session. Discover which S&P500 stocks are making waves on Friday.

Via Chartmill

Why Is Gilead Sciences (GILD) Stock Rocketing Higher Today

August 08, 2025

Shares of biopharmaceutical company Gilead Sciences (NASDAQ:GILD) jumped 8.7% in the morning session after the company reported second-quarter 2025 results that topped Wall Street's expectations and...

Via StockStory

Topics Earnings

Gilead Lifts Annual Outlook As Yeztugo Launch Nears ↗

August 08, 2025

Gilead raised its 2025 earnings and sales outlook after posting better-than-expected Q2 results, led by strong HIV and oncology drug sales.

Via Benzinga

SoundHound AI, Ouster, Globalstar, Doximity, JFrog And Other Big Stocks Moving Higher On Friday ↗

August 08, 2025

Via Benzinga

Topics Artificial Intelligence

Discover the top S&P500 movers in Friday's pre-market session. ↗

August 08, 2025

Stay updated with the S&P500 stocks that are on the move in today's pre-market session.

Via Chartmill

Gilead Sciences (GILD) Q2 2025 Earnings Call Transcript ↗

August 08, 2025

Via The Motley Fool

Topics Earnings

Gilead Sciences (NASDAQ:GILD) Beats Q2 Sales Targets

August 07, 2025

Biopharmaceutical company Gilead Sciences (NASDAQ:GILD) reported Q2 CY2025 results topping the market’s revenue expectations, with sales up 1.8% year on year to $7.08 billion. On the other hand, the...

Via StockStory

Will Gilead's Beat-And-Raise Help It Leapfrog Its 50-Day Line Ceiling? ↗

August 07, 2025

Gilead Sciences boosted its full-year outlook after beating expectations. Gilead stock is hitting a 50-day line ceiling.

Via Investor's Business Daily

Gilead Sciences Announces Second Quarter 2025 Financial Results

August 07, 2025

From Gilead Sciences, Inc.

Via Business Wire

How To Earn $500 A Month From Gilead Sciences Stock Ahead Of Q2 Earnings ↗

August 07, 2025

Via Benzinga

Apple Jumps, Eli Lilly Crashes On Worst Day In 25 Years: What's Moving Markets Thursday? ↗

August 07, 2025

U.S. equities slipped midday Thursday as corporate earnings and fresh tariff announcements from President Donald Trump drove divergent moves in heavyweight names.

Via Benzinga

Topics Government World Trade

Arcus (RCUS) Q2 Revenue Jumps 310% ↗

August 06, 2025

Via The Motley Fool

Upcoming Earnings Calls This Week: August 4th - August 10th, 2025

August 07, 2025

This week, from August 4th to August 10th, 2025, marks a busy period in the second-quarter earnings season, with hundreds of companies across various sectors scheduled to report their financial...

Via MarketMinute

Topics Artificial Intelligence Economy

Gilead Sciences Inc (NASDAQ:GILD) Meets Caviar Cruise Quality Investing Criteria ↗

August 06, 2025

The Caviar Cruise strategy identifies high-quality stocks like Gilead Sciences (GILD) for long-term investment, focusing on strong growth, ROIC, low debt, and solid cash flow. GILD excels in...

Via Chartmill

Topics Economy

Gilead Sciences (GILD) Reports Q2: Everything You Need To Know Ahead Of Earnings

August 05, 2025

Biopharmaceutical company Gilead Sciences (NASDAQ:GILD) will be reporting results this Thursday after market close. Here’s what investors should know.

Via StockStory

Topics Artificial Intelligence World Trade

Tango (TNGX) Q2 Revenue Drops 52% ↗

August 05, 2025

Via The Motley Fool

Topics Intellectual Property

GILEAD SCIENCES INC (NASDAQ:GILD) Shows Strong Technical Breakout Potential with High Ratings ↗

August 04, 2025

Gilead Sciences (GILD) shows strong technical breakout potential with a high Technical Rating (10) and Setup Rating (8), indicating upward momentum and consolidation before a possible breakout.

Via Chartmill

< Previous 1 2 3 4 5 6 7 8 9

...

69 70 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.